Updates on campus events, policies, construction and more.


Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.


Visit the News Hub

Memory loss caused by West Nile virus explained

Study identifies targets for prevention, treatment

by Tamara BhandariJune 22, 2016

CDC/ James Gathany

Every year as mosquito season arrives, so does West Nile virus, causing fever in thousands of people nationwide and life-threatening brain infections in an unlucky few. About half the people who survive that infection – West Nile encephalitis – are left with permanent neurological deficits such as memory loss.

New research shows that these long-term neurological problems may be due to the patient’s own immune system destroying parts of the neurons in the brain, which suggests that intervening in the immune response may help prevent brain damage so patients can recover.

The study is published June 22 in Nature.

West Nile was first identified in the Western Hemisphere in 1999, when groups of birds began dying in New York and a veterinary pathologist at the Bronx Zoo brought the deaths to the attention of the Centers for Disease Control and Prevention. The virus has since spread throughout the Americas, infecting millions of people. Ten thousand West Nile survivors are living with long-term neurological problems such as fatigue, weakness, difficulty walking and memory loss, and the number goes up by about 1,000 every year following mosquito season. There is no vaccine or specific treatment for West Nile infection.

“When I talk with other doctors about West Nile patients with these persistent neurological deficits, many say, ‘The virus in their brains must have killed neurons, and there’s nothing we can do about it,’” said Robyn Klein, MD, PhD, a professor of medicine and the study’s senior author. “My thinking has been, if we can determine what triggers this brain damage, maybe we can prevent it from happening or stop it afterwards.’”

Klein, postdoctoral researcher Michael Vasek, PhD, and colleagues developed a mouse model of West Nile encephalitis by injecting a weakened strain of the virus directly on top of the mouse hippocampus, a region of the brain important for memory. A month after the mice had recovered from the infection, the researchers tested the animals’ ability to navigate a maze.

Much like West Nile survivors who cannot navigate their neighborhoods, the infected mice could not remember how to navigate the maze. But contrary to conventional wisdom, their hippocampal neurons hadn’t been killed by the virus.

Instead, the researchers found that microglial cells, a kind of immune cell that lives in the brain, were clustered around the neurons at the site of infection and were highly activated – “on fire,” as Klein put it.

Moreover, levels of an immune protein called complement were high in the brains of mice with memory loss. Neurons make connections to each other at junctions called synapses, allowing information to be passed from cell to cell. During normal brain development, many more synapses are formed than needed and only those that are strengthened should persist. Complement tags the weak synapses to be removed, and the activated microglia destroy them.

In the mice with memory loss, viral infection seemed to have sent this system into overdrive, leading to the destruction of necessary synapses. Synapses must be formed or strengthened for learning and memory to occur.  While the neurons near the activated microglia were still alive, they lacked synapses. The more synapses that were destroyed, the worse the mouse’s memory problems.

Robyn Klein, MD, PhD, and Michael Vasek, PhD, examine images of mouse synapses. The researchers found that memory loss suffered by some survivors of West Nile encephalitis may be caused by the loss of synapses between neurons.Robert Boston
Robyn Klein, MD, PhD, and Michael Vasek, PhD, examine images of mouse synapses. The researchers found that memory loss suffered by some survivors of West Nile encephalitis may be caused by the loss of synapses between neurons.

“There’s never been any model of cognitive dysfunction due to brain infection that shows that eliminating synapses without loss of neurons could cause these symptoms,” said Klein, who is also a professor of pathology and immunology, and of neuroscience. “It’s really a paradigm-shifting idea that a viral infection can do this. It also makes us wonder whether these mechanisms are involved in other diseases associated with memory loss.”

Healthy people create new synapses throughout life as they learn new things. West Nile survivors, however, may be unable to grow new synapses to replace the ones lost during their bouts of encephalitis.

“The microglia remain activated long after the virus is cleared, and this may be preventing the synapses from recovering,” Klein said. “But that gives us hope that we can develop interventions directed at the immune response. We think we can treat this, and that’s what we’re trying to do.”

Update: Details in this news release regarding how West Nile virus first was identified in the Western Hemisphere have been corrected.

Vasek MJ, Garber C, Dorsey D, Durrant DM, Bollman B, Soung A, Yu J, Perez-torres C, Frouin A, Wilton DK, Funk K, DeMasters BK, Jiang X, Bowen JR, Mennerick S, Robinson JK, Garbow JR, Tyler KL, Suthar MS, Schmidt RE, Stevens B, Klein RS. A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature. June 22, 2016.

Funding for this research was provided by the National Institutes of Health (NIH), grant numbers F31 NS077640, R01 NS052632 and U19 AI083019.

Washington University School of Medicine‘s 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.

Tamara covers infectious diseases, molecular microbiology, neurology, neuroscience, surgery, the Institute for Informatics, the Division of Physician-Scientists and the MSTP program. She holds a double bachelor's degree in molecular biophysics & biochemistry and in sociology from Yale University, a master's in public health from the University of California, Berkeley, and a PhD in biomedical science from the University of California, San Diego. She joined WashU Medicine Marketing & Communications in 2016. She has received three Robert G. Fenley writing awards from the American Association of Medical Colleges: a bronze in 2020 for "Mind’s quality control center found in long-ignored brain area," a silver in 2022 for "Mice with hallucination-like behaviors reveal insight into psychotic illness," and a bronze in 2023 for "Race of people given Alzheimer’s blood tests may affect interpretation of results." Since January of 2024, Tamara has been writing under the name Tamara Schneider.